NIF SMBC VENTURES
NIF SMBC Ventures USA, Inc. is out of business. It is a venture capital firm specializing in investments at any stage of company development with a focus on earlier round financings. It typically invests between $1 million and $10 million in its portfolio companies. The firm’s investments tend to spread over several rounds of financing. It looks for products and services that addressed large emerging markets with the potential to be at least $100 million in a few years and more. The firm seeks to take a board seat in its portfolio companies. NIF SMBC Ventures USA, Inc. was founded in 1996 and is based in Palo Alto, California.
NIF SMBC VENTURES
Status:
Active
Similar Organizations
CoMotion Venture Capital
CoMotion Venture Capital is out of business. It is a venture capital firm specializing in start up, expansion capital, and early stage
Samsung Ventures
Samsung Ventures is a venture capital firm specializing in investments in start-up companies.
Venrock
Venrock is a venture capital firm investing in technology and healthcare companies.
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2008-06-11 | Gene Techno Science | NIF SMBC Ventures investment in Venture Round - Gene Techno Science | 500.25 M JPY |
2008-05-06 | REGiMMUNE | NIF SMBC Ventures investment in Series B - REGiMMUNE | 8 M USD |
2008-02-01 | REGiMMUNE | NIF SMBC Ventures investment in Series B - REGiMMUNE | 6 M USD |
2007-07-03 | Diatos | NIF SMBC Ventures investment in Series D - Diatos | 12.8 M USD |
2007-02-21 | REGiMMUNE | NIF SMBC Ventures investment in Series A - REGiMMUNE | 4.2 M USD |
2007-01-25 | Novexel | NIF SMBC Ventures investment in Series B - Novexel | 65 M USD |
2007-01-08 | Digital Media Group | NIF SMBC Ventures investment in Series B - Digital Media Group | N/A |
2006-11-12 | Abionyx Pharma | NIF SMBC Ventures investment in Series B - Abionyx Pharma | 53.5 M USD |
2006-08-15 | REGiMMUNE | NIF SMBC Ventures investment in Seed Round - REGiMMUNE | 1.6 M USD |
2005-08-22 | Abionyx Pharma | NIF SMBC Ventures investment in Series A - Abionyx Pharma | 30.5 M USD |